Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ferric carboxymaltose for postoperative anemia after knee prosthesis surgery
2010-023038-22Phase 4Active
- Sponsor
- Parc de Salut Mar
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ferric carboxymaltose in postoperative anemia (2 arms), sponsored by Parc de Salut Mar. Primary endpoint: Change in hemoglobin at day 7. Started Jan 2012; status: active.
02
Drugs
ferric carboxymaltose
03
Conditions
postoperative anemia
Beyond the preview
Go deeper on 2010-023038-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023038-22.